<!DOCTYPE html>
<html lang="cn">
<head>
  <meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=2">
<meta name="theme-color" content="#222">
<meta name="generator" content="Hexo 5.4.0">

<link rel="preconnect" href="https://fonts.googleapis.com" crossorigin>
<link rel="preconnect" href="https://cdn.jsdelivr.net" crossorigin>
  <link rel="apple-touch-icon" sizes="180x180" href="/images/site-icon.jpg">
  <link rel="icon" type="image/png" sizes="32x32" href="/images/site-icon.jpg">
  <link rel="icon" type="image/png" sizes="16x16" href="/images/site-icon.jpg">
  <link rel="mask-icon" href="/images/site-icon.jpg" color="#222">
  <meta name="google-site-verification" content="bbrDOoVIlRq8ILDaV3dOe1EQ8RE8RSQBrNnrdfTplCE">
  <meta name="baidu-site-verification" content="q9emFHNSuh">

<link rel="stylesheet" href="/css/main.css">

<link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Noto+Sans+SC:300,300italic,400,400italic,700,700italic%7CNoto+Serif:300,300italic,400,400italic,700,700italic%7CFira+Code:300,300italic,400,400italic,700,700italic&display=swap&subset=latin,latin-ext">

<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@5.15.3/css/all.min.css" integrity="sha256-2H3fkXt6FEmrReK448mDVGKb3WW2ZZw35gI7vqHOE4Y=" crossorigin="anonymous">
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/animate.css@3.1.1/animate.min.css" integrity="sha256-PR7ttpcvz8qrF57fur/yAx1qXMFJeJFiA6pSzWi0OIE=" crossorigin="anonymous">
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fancyapps/fancybox@3.5.7/dist/jquery.fancybox.min.css" integrity="sha256-Vzbj7sDDS/woiFS3uNKo8eIuni59rjyNGtXfstRzStA=" crossorigin="anonymous">
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/nprogress@0.2.0/nprogress.css" integrity="sha256-no0c5ccDODBwp+9hSmV5VvPpKwHCpbVzXHexIkupM6U=" crossorigin="anonymous">
  <script src="https://cdn.jsdelivr.net/npm/nprogress@0.2.0/nprogress.js" integrity="sha256-a5YRB27CcBwBFcT5EF/f3E4vzIqyHrSR878nseNYw64=" crossorigin="anonymous"></script>

<script class="next-config" data-name="main" type="application/json">{&quot;hostname&quot;:&quot;www.aloha.org.cn&quot;,&quot;root&quot;:&quot;&#x2F;&quot;,&quot;images&quot;:&quot;&#x2F;images&quot;,&quot;scheme&quot;:&quot;Mist&quot;,&quot;version&quot;:&quot;8.4.0&quot;,&quot;exturl&quot;:true,&quot;sidebar&quot;:{&quot;position&quot;:&quot;left&quot;,&quot;display&quot;:&quot;post&quot;,&quot;padding&quot;:18,&quot;offset&quot;:12,&quot;width&quot;:320},&quot;copycode&quot;:true,&quot;bookmark&quot;:{&quot;enable&quot;:true,&quot;color&quot;:&quot;#222&quot;,&quot;save&quot;:&quot;auto&quot;},&quot;fancybox&quot;:true,&quot;mediumzoom&quot;:false,&quot;lazyload&quot;:true,&quot;pangu&quot;:false,&quot;comments&quot;:{&quot;style&quot;:&quot;tabs&quot;,&quot;active&quot;:&quot;utterances&quot;,&quot;storage&quot;:true,&quot;lazyload&quot;:true,&quot;nav&quot;:{&quot;utterances&quot;:{&quot;text&quot;:&quot;Comment with utterances&quot;,&quot;order&quot;:1}},&quot;activeClass&quot;:&quot;utterances&quot;},&quot;motion&quot;:{&quot;enable&quot;:true,&quot;async&quot;:true,&quot;transition&quot;:{&quot;post_block&quot;:&quot;fadeIn&quot;,&quot;post_header&quot;:&quot;fadeInDown&quot;,&quot;post_body&quot;:&quot;fadeInDown&quot;,&quot;coll_header&quot;:&quot;fadeInLeft&quot;,&quot;sidebar&quot;:&quot;fadeInUp&quot;}},&quot;prism&quot;:false,&quot;i18n&quot;:{&quot;placeholder&quot;:&quot;Searching...&quot;,&quot;empty&quot;:&quot;We didn&#39;t find any results for the search: ${query}&quot;,&quot;hits_time&quot;:&quot;${hits} results found in ${time} ms&quot;,&quot;hits&quot;:&quot;${hits} results found&quot;},&quot;path&quot;:&quot;&#x2F;search.xml&quot;,&quot;localsearch&quot;:{&quot;enable&quot;:true,&quot;trigger&quot;:&quot;auto&quot;,&quot;top_n_per_article&quot;:-1,&quot;unescape&quot;:false,&quot;preload&quot;:false}}</script>
<meta name="description" content="抗原（antigen, Ag） 所有能激活和诱导免疫应答的物质。 通常指能被 T、B 淋巴细胞表面特异性抗原受体识别及结合，激活 T、B 细胞增殖、分化、产生免疫应答效应产物（免疫原性），并与效应产物结合（免疫反应性），进而发挥适应性免疫应答效应的物质。">
<meta property="og:type" content="article">
<meta property="og:title" content="抗原">
<meta property="og:url" content="https://www.aloha.org.cn/Learning/Medicine/%E5%8C%BB%E5%AD%A6%E5%85%8D%E7%96%AB%E5%AD%A6/%E6%8A%97%E5%8E%9F/">
<meta property="og:site_name" content="Aloha&#39;s Blog">
<meta property="og:description" content="抗原（antigen, Ag） 所有能激活和诱导免疫应答的物质。 通常指能被 T、B 淋巴细胞表面特异性抗原受体识别及结合，激活 T、B 细胞增殖、分化、产生免疫应答效应产物（免疫原性），并与效应产物结合（免疫反应性），进而发挥适应性免疫应答效应的物质。">
<meta property="og:locale">
<meta property="article:published_time" content="2021-04-30T02:36:22.000Z">
<meta property="article:modified_time" content="2021-07-16T12:20:05.288Z">
<meta property="article:author" content="Qihuan Liu">
<meta property="article:tag" content="医学免疫学">
<meta name="twitter:card" content="summary">


<link rel="canonical" href="https://www.aloha.org.cn/Learning/Medicine/%E5%8C%BB%E5%AD%A6%E5%85%8D%E7%96%AB%E5%AD%A6/%E6%8A%97%E5%8E%9F/">



<script class="next-config" data-name="page" type="application/json">{&quot;sidebar&quot;:&quot;&quot;,&quot;isHome&quot;:false,&quot;isPost&quot;:true,&quot;lang&quot;:&quot;cn&quot;,&quot;comments&quot;:true,&quot;permalink&quot;:&quot;https:&#x2F;&#x2F;www.aloha.org.cn&#x2F;Learning&#x2F;Medicine&#x2F;%E5%8C%BB%E5%AD%A6%E5%85%8D%E7%96%AB%E5%AD%A6&#x2F;%E6%8A%97%E5%8E%9F&#x2F;&quot;,&quot;path&quot;:&quot;Learning&#x2F;Medicine&#x2F;医学免疫学&#x2F;抗原&#x2F;&quot;,&quot;title&quot;:&quot;抗原&quot;}</script>

<script class="next-config" data-name="calendar" type="application/json">&quot;&quot;</script>
<title>抗原 | Aloha's Blog</title><script src="/js/config.js"></script><script src="/lib/fireworks.js"></script>
  





  <!-- <script src="/js/hoverdetail.js"></script> -->

  <noscript>
    <link rel="stylesheet" href="/css/noscript.css">
  </noscript>
<link rel="alternate" href="/atom.xml" title="Aloha's Blog" type="application/atom+xml">
<link rel="alternate" href="/rss2.xml" title="Aloha's Blog" type="application/rss+xml">
</head>

<body itemscope itemtype="http://schema.org/WebPage" class="use-motion">
  <div class="headband"></div>

  <main class="main">
    <header class="header" itemscope itemtype="http://schema.org/WPHeader">
      <div class="header-inner"><div class="site-brand-container">
  <div class="site-nav-toggle">
    <div class="toggle" aria-label="Toggle navigation bar" role="button">
        <span class="toggle-line"></span>
        <span class="toggle-line"></span>
        <span class="toggle-line"></span>
    </div>
  </div>

  <div class="site-meta">

    <a href="/" class="brand" rel="start">
      <i class="logo-line"></i>
      <h1 class="site-title">Aloha's Blog</h1>
      <i class="logo-line"></i>
    </a>
      <p class="site-subtitle" itemprop="description">不乱于心，不困于情。不畏将来，不念过往。</p>
  </div>

  <div class="site-nav-right">
    <div class="toggle popup-trigger">
        <i class="fa fa-search fa-fw fa-lg"></i>
    </div>
  </div>
</div>



<nav class="site-nav">
  <ul class="main-menu menu">
        <li class="menu-item menu-item-home"><a href="/" rel="section"><i class="fa fa-home fa-fw"></i>Home</a></li>
        <li class="menu-item menu-item-about"><a href="/about/" rel="section"><i class="fa fa-user fa-fw"></i>About</a></li>
        <li class="menu-item menu-item-tags"><a href="/tags/" rel="section"><i class="fa fa-tags fa-fw"></i>Tags<span class="badge">23</span></a></li>
        <li class="menu-item menu-item-categories"><a href="/categories/" rel="section"><i class="fa fa-th fa-fw"></i>Categories<span class="badge">22</span></a></li>
        <li class="menu-item menu-item-archives"><a href="/archives/" rel="section"><i class="fa fa-archive fa-fw"></i>Archives<span class="badge">65</span></a></li>
      <li class="menu-item menu-item-search">
        <a role="button" class="popup-trigger"><i class="fa fa-search fa-fw"></i>Search
        </a>
      </li>
  </ul>
</nav>



  <div class="search-pop-overlay">
    <div class="popup search-popup"><div class="search-header">
  <span class="search-icon">
    <i class="fa fa-search"></i>
  </span>
  <div class="search-input-container">
    <input autocomplete="off" autocapitalize="off" maxlength="80"
           placeholder="Searching..." spellcheck="false"
           type="search" class="search-input">
  </div>
  <span class="popup-btn-close" role="button">
    <i class="fa fa-times-circle"></i>
  </span>
</div>
<div class="search-result-container no-result">
  <div class="search-result-icon">
    <i class="fa fa-spinner fa-pulse fa-5x"></i>
  </div>
</div>

    </div>
  </div>

</div>
        
  
  <div class="toggle sidebar-toggle" role="button">
    <span class="toggle-line"></span>
    <span class="toggle-line"></span>
    <span class="toggle-line"></span>
  </div>

  <aside class="sidebar">

    <div class="sidebar-inner sidebar-nav-active sidebar-toc-active">
      <ul class="sidebar-nav">
        <li class="sidebar-nav-toc">
          Table of Contents
        </li>
        <li class="sidebar-nav-overview">
          Overview
        </li>
      </ul>

      <div class="sidebar-panel-container">
        <!--noindex-->
        <div class="post-toc-wrap sidebar-panel">
            <div class="post-toc animated"><ol class="nav"><li class="nav-item nav-level-2"><a class="nav-link" href="#%E6%8A%97%E5%8E%9F%E7%9A%84%E6%80%A7%E8%B4%A8%E4%B8%8E%E5%88%86%E5%AD%90%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80"><span class="nav-number">1.</span> <span class="nav-text">抗原的性质与分子结构基础 </span></a><ol class="nav-child"><li class="nav-item nav-level-3"><a class="nav-link" href="#%E6%8A%97%E5%8E%9F%E7%9A%84%E5%9F%BA%E6%9C%AC%E7%89%B9%E5%BE%81"><span class="nav-number">1.1.</span> <span class="nav-text">抗原的基本特征 </span></a></li><li class="nav-item nav-level-3"><a class="nav-link" href="#%E9%80%82%E5%BA%94%E6%80%A7%E5%85%8D%E7%96%AB%E5%BA%94%E7%AD%94%E7%9A%84%E6%8A%97%E5%8E%9F%E7%89%B9%E5%BC%82%E6%80%A7"><span class="nav-number">1.2.</span> <span class="nav-text">适应性免疫应答的抗原特异性 </span></a><ol class="nav-child"><li class="nav-item nav-level-4"><a class="nav-link" href="#%E6%8A%97%E5%8E%9F%E7%89%B9%E5%BC%82%E6%80%A7%E4%B8%8E%E6%8A%97%E5%8E%9F%E8%A1%A8%E4%BD%8D"><span class="nav-number">1.2.1.</span> <span class="nav-text">抗原特异性与抗原表位 </span></a></li><li class="nav-item nav-level-4"><a class="nav-link" href="#%E6%8A%97%E5%8E%9F%E8%A1%A8%E4%BD%8D%E7%9A%84%E5%88%86%E7%B1%BB"><span class="nav-number">1.2.2.</span> <span class="nav-text">抗原表位的分类 </span></a></li><li class="nav-item nav-level-4"><a class="nav-link" href="#%E5%8D%8A%E6%8A%97%E5%8E%9F-%E8%BD%BD%E4%BD%93%E5%8F%8D%E5%BA%94"><span class="nav-number">1.2.3.</span> <span class="nav-text">半抗原-载体反应 </span></a></li><li class="nav-item nav-level-4"><a class="nav-link" href="#%E5%85%B1%E5%90%8C%E6%8A%97%E5%8E%9F%E8%A1%A8%E4%BD%8D%E4%B8%8E%E4%BA%A4%E5%8F%89%E5%8F%8D%E5%BA%94"><span class="nav-number">1.2.4.</span> <span class="nav-text">共同抗原表位与交叉反应 </span></a></li></ol></li></ol></li><li class="nav-item nav-level-2"><a class="nav-link" href="#%E5%BD%B1%E5%93%8D%E6%8A%97%E5%8E%9F%E5%85%8D%E7%96%AB%E5%8E%9F%E6%80%A7%E7%9A%84%E5%9B%A0%E7%B4%A0"><span class="nav-number">2.</span> <span class="nav-text">影响抗原免疫原性的因素 </span></a><ol class="nav-child"><li class="nav-item nav-level-3"><a class="nav-link" href="#%E6%8A%97%E5%8E%9F%E5%88%86%E5%AD%90%E7%9A%84%E7%90%86%E5%8C%96%E4%B8%8E%E7%BB%93%E6%9E%84%E6%80%A7%E8%B4%A8"><span class="nav-number">2.1.</span> <span class="nav-text">抗原分子的理化与结构性质 </span></a></li><li class="nav-item nav-level-3"><a class="nav-link" href="#%E5%AE%BF%E4%B8%BB%E7%9A%84%E7%89%B9%E6%80%A7"><span class="nav-number">2.2.</span> <span class="nav-text">宿主的特性 </span></a></li><li class="nav-item nav-level-3"><a class="nav-link" href="#%E6%8A%97%E5%8E%9F%E8%BF%9B%E5%85%A5%E5%AE%BF%E4%B8%BB%E7%9A%84%E6%96%B9%E5%BC%8F"><span class="nav-number">2.3.</span> <span class="nav-text">抗原进入宿主的方式 </span></a></li></ol></li><li class="nav-item nav-level-2"><a class="nav-link" href="#%E6%8A%97%E5%8E%9F%E7%9A%84%E7%A7%8D%E7%B1%BB"><span class="nav-number">3.</span> <span class="nav-text">抗原的种类 </span></a><ol class="nav-child"><li class="nav-item nav-level-3"><a class="nav-link" href="#%E6%A0%B9%E6%8D%AE%E8%AF%B1%E7%94%9F%E6%8A%97%E4%BD%93%E6%97%B6%E6%98%AF%E5%90%A6%E9%9C%80%E8%A6%81-th-%E7%BB%86%E8%83%9E%E5%8F%82%E4%B8%8E"><span class="nav-number">3.1.</span> <span class="nav-text">根据诱生抗体时是否需要 Th 细胞参与 </span></a></li><li class="nav-item nav-level-3"><a class="nav-link" href="#%E6%A0%B9%E6%8D%AE%E6%8A%97%E5%8E%9F%E4%B8%8E%E6%9C%BA%E4%BD%93%E7%9A%84%E4%BA%B2%E7%BC%98%E5%85%B3%E7%B3%BB"><span class="nav-number">3.2.</span> <span class="nav-text">根据抗原与机体的亲缘关系 </span></a></li><li class="nav-item nav-level-3"><a class="nav-link" href="#%E6%A0%B9%E6%8D%AE%E6%8A%97%E5%8E%9F%E6%8F%90%E5%91%88%E7%BB%86%E8%83%9E%E5%86%85%E6%8A%97%E5%8E%9F%E7%9A%84%E6%9D%A5%E6%BA%90"><span class="nav-number">3.3.</span> <span class="nav-text">根据抗原提呈细胞内抗原的来源 </span></a></li></ol></li><li class="nav-item nav-level-2"><a class="nav-link" href="#%E9%9D%9E%E7%89%B9%E5%BC%82%E6%80%A7%E5%85%8D%E7%96%AB%E5%88%BA%E6%BF%80%E5%89%82"><span class="nav-number">4.</span> <span class="nav-text">非特异性免疫刺激剂 </span></a><ol class="nav-child"><li class="nav-item nav-level-3"><a class="nav-link" href="#%E8%B6%85%E6%8A%97%E5%8E%9F"><span class="nav-number">4.1.</span> <span class="nav-text">超抗原 </span></a></li><li class="nav-item nav-level-3"><a class="nav-link" href="#%E4%BD%90%E5%89%82"><span class="nav-number">4.2.</span> <span class="nav-text">佐剂 </span></a><ol class="nav-child"><li class="nav-item nav-level-4"><a class="nav-link" href="#%E4%BD%90%E5%89%82%E7%9A%84%E7%B1%BB%E5%9E%8B"><span class="nav-number">4.2.1.</span> <span class="nav-text">佐剂的类型 </span></a></li><li class="nav-item nav-level-4"><a class="nav-link" href="#%E4%BD%90%E5%89%82%E4%BD%9C%E7%94%A8%E6%9C%BA%E5%88%B6"><span class="nav-number">4.2.2.</span> <span class="nav-text">佐剂作用机制 </span></a></li></ol></li><li class="nav-item nav-level-3"><a class="nav-link" href="#%E4%B8%9D%E8%A3%82%E5%8E%9F"><span class="nav-number">4.3.</span> <span class="nav-text">丝裂原 </span></a></li></ol></li></ol></div>
        </div>
        <!--/noindex-->

        <div class="site-overview-wrap sidebar-panel">
          <div class="site-author site-overview-item animated" itemprop="author" itemscope itemtype="http://schema.org/Person">
    <img class="site-author-image" itemprop="image" alt="Qihuan Liu"
      src="/images/avatar.gif">
  <p class="site-author-name" itemprop="name">Qihuan Liu</p>
  <div class="site-description" itemprop="description">追寻罗素先生的脚步，渴望寻找到我想要的答案。</div>
</div>
<div class="sidebar-quote">
<p class="sidebar-quote-content" onclick="toggleFull()">主人不来过夜半，闲敲棋子落灯花。</p>
<p class="sidebar-quote-from">——</p>
</div>
<script src="https://sdk.jinrishici.com/v2/browser/jinrishici.js" charset="utf-8"></script>
<script type="text/javascript">
  var poem_part, poem_full
  jinrishici.load(function(result) {
    var sentence = document.querySelector(".sidebar-quote-content")
    var info = document.querySelector(".sidebar-quote-from")
    poem_part = sentence.innerHTML = result.data.content
    info.innerHTML = '——' + result.data.origin.dynasty + '·' + result.data.origin.author + '《' + result.data.origin.title + '》'
    const indent = "&nbsp".repeat(8)
    poem_full = indent + result.data.origin.content.join('<br/>' + indent)
  });
  var FULLYSHOWED = false;
  function toggleFull() {
    var sentence = document.querySelector(".sidebar-quote-content")
    if (FULLYSHOWED) {
      sentence.innerHTML = poem_part
      /* sentence.style["text-align"] = "left" */
      FULLYSHOWED = false
    } else {
      sentence.innerHTML = poem_full
      /* sentence.style["text-align"] = "center" */
      FULLYSHOWED = true
    }
  }
</script>
<!-- require APlayer -->
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/aplayer/dist/APlayer.min.css">
<script src="https://cdn.jsdelivr.net/npm/aplayer/dist/APlayer.min.js"></script>
<!-- require MetingJS -->
<script src="https://cdn.jsdelivr.net/npm/meting@2/dist/Meting.min.js"></script>

<meting-js
  server="netease"
  type="playlist"
  id="6822976600"
  mini="false"
  fixed="false"
  list-folded="NaN"
  autoplay="false"
  volume="0.4"
  theme=""
  order="random"
  loop="all"
  preload="auto"
  mutex="true">
</meting-js>
<div class="site-state-wrap site-overview-item animated">
  <nav class="site-state">
      <div class="site-state-item site-state-posts">
          <a href="/archives/">
        
          <span class="site-state-item-count">65</span>
          <span class="site-state-item-name">posts</span>
        </a>
      </div>
      <div class="site-state-item site-state-categories">
            <a href="/categories/">
          
        <span class="site-state-item-count">22</span>
        <span class="site-state-item-name">categories</span></a>
      </div>
      <div class="site-state-item site-state-tags">
            <a href="/tags/">
          
        <span class="site-state-item-count">23</span>
        <span class="site-state-item-name">tags</span></a>
      </div>
  </nav>
</div>


  <div class="feed-link motion-element">
    <a href="/atom.xml" rel="alternate">
      <i class="fa fa-rss"></i>
      RSS
    </a>
  </div>

  <div class="links-of-author site-overview-item animated">
      <span class="links-of-author-item">
        <span class="exturl" data-url="aHR0cHM6Ly9naXRodWIuY29tL2Fsb2hhaWE=" title="GitHub → https:&#x2F;&#x2F;github.com&#x2F;alohaia"><i class="fab fa-github fa-fw"></i>GitHub</span>
      </span>
      <span class="links-of-author-item">
        <span class="exturl" data-url="bWFpbHRvOmxpdS5xaWh1YW5Ab3V0bG9vay5jb20=" title="E-Mail → mailto:liu.qihuan@outlook.com"><i class="fa fa-envelope fa-fw"></i>E-Mail</span>
      </span>
  </div>


  <div class="links-of-blogroll site-overview-item animated">
    <div class="links-of-blogroll-title"><i class="fa fa-globe fa-fw"></i>
      Links
    </div>
    <ul class="links-of-blogroll-list">
        <li class="links-of-blogroll-item">
          <span class="exturl" data-url="aHR0cHM6Ly93d3cuc2Rpb3BpZC50b3Av" title="https:&#x2F;&#x2F;www.sdiopid.top&#x2F;">SDIOPID</span>
        </li>
    </ul>
  </div>

        </div>
      </div>
        <div class="back-to-top animated" role="button" aria-label="Back to top">
          <i class="fa fa-arrow-up"></i>
          <span>0%</span>
        </div>
    </div>
  </aside>
  <div class="sidebar-dimmer"></div>


    </header>

    
  <div class="reading-progress-bar"></div>
  <a role="button" class="book-mark-link book-mark-link-fixed"></a>

  <span class="exturl github-corner" data-url="aHR0cHM6Ly9naXRodWIuY29tL2Fsb2hhaWE=" title="Follow me on GitHub" aria-label="Follow me on GitHub"><svg width="80" height="80" viewBox="0 0 250 250" aria-hidden="true"><path d="M0,0 L115,115 L130,115 L142,142 L250,250 L250,0 Z"></path><path d="M128.3,109.0 C113.8,99.7 119.0,89.6 119.0,89.6 C122.0,82.7 120.5,78.6 120.5,78.6 C119.2,72.0 123.4,76.3 123.4,76.3 C127.3,80.9 125.5,87.3 125.5,87.3 C122.9,97.6 130.6,101.9 134.4,103.2" fill="currentColor" style="transform-origin: 130px 106px;" class="octo-arm"></path><path d="M115.0,115.0 C114.9,115.1 118.7,116.5 119.8,115.4 L133.7,101.6 C136.9,99.2 139.9,98.4 142.2,98.6 C133.8,88.0 127.5,74.4 143.8,58.0 C148.5,53.4 154.0,51.2 159.7,51.0 C160.3,49.4 163.2,43.6 171.4,40.1 C171.4,40.1 176.1,42.5 178.8,56.2 C183.1,58.6 187.2,61.8 190.9,65.4 C194.5,69.0 197.7,73.2 200.1,77.6 C213.8,80.2 216.3,84.9 216.3,84.9 C212.7,93.1 206.9,96.0 205.4,96.6 C205.1,102.4 203.0,107.8 198.3,112.5 C181.9,128.9 168.3,122.5 157.7,114.1 C157.9,116.9 156.7,120.9 152.7,124.9 L141.0,136.5 C139.8,137.7 141.6,141.9 141.8,141.8 Z" fill="currentColor" class="octo-body"></path></svg></span>

<noscript>
  <div class="noscript-warning">Theme NexT works best with JavaScript enabled</div>
</noscript>


    <div class="main-inner post posts-expand">


  


<div class="post-block">
  
  

  <article itemscope itemtype="http://schema.org/Article" class="post-content" lang="cn">
    <link itemprop="mainEntityOfPage" href="https://www.aloha.org.cn/Learning/Medicine/%E5%8C%BB%E5%AD%A6%E5%85%8D%E7%96%AB%E5%AD%A6/%E6%8A%97%E5%8E%9F/">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="/images/avatar.gif">
      <meta itemprop="name" content="Qihuan Liu">
      <meta itemprop="description" content="追寻罗素先生的脚步，渴望寻找到我想要的答案。">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="Aloha's Blog">
    </span>
      <header class="post-header">
        <h1 class="post-title" itemprop="name headline">
          抗原
        </h1>

        <div class="post-meta-container">
          <div class="post-meta">
    <span class="post-meta-item">
      <span class="post-meta-item-icon">
        <i class="far fa-calendar"></i>
      </span>
      <span class="post-meta-item-text">Posted on</span>

      <time title="Created: 2021-04-30 10:36:22" itemprop="dateCreated datePublished" datetime="2021-04-30T10:36:22+08:00">2021-04-30</time>
    </span>
      <span class="post-meta-item">
        <span class="post-meta-item-icon">
          <i class="far fa-calendar-check"></i>
        </span>
        <span class="post-meta-item-text">Edited on</span>
        <time title="Modified: 2021-07-16 20:20:05" itemprop="dateModified" datetime="2021-07-16T20:20:05+08:00">2021-07-16</time>
      </span>
    <span class="post-meta-item">
      <span class="post-meta-item-icon">
        <i class="far fa-folder"></i>
      </span>
      <span class="post-meta-item-text">In</span>
        <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
          <a href="/categories/Learning/" itemprop="url" rel="index"><span itemprop="name">Learning</span></a>
        </span>
          , 
        <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
          <a href="/categories/Learning/Medicine/" itemprop="url" rel="index"><span itemprop="name">Medicine</span></a>
        </span>
          , 
        <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
          <a href="/categories/Learning/Medicine/%E5%8C%BB%E5%AD%A6%E5%85%8D%E7%96%AB%E5%AD%A6/" itemprop="url" rel="index"><span itemprop="name">医学免疫学</span></a>
        </span>
    </span>

  
      </div>
      <div class="post-meta">
    <span class="post-meta-item" title="Symbols count in article">
      <span class="post-meta-item-icon">
        <i class="far fa-file-word"></i>
      </span>
      <span class="post-meta-item-text">Symbols count in article: </span>
      <span>3.5k</span>
    </span>
    <span class="post-meta-item" title="Reading time">
      <span class="post-meta-item-icon">
        <i class="far fa-clock"></i>
      </span>
      <span class="post-meta-item-text">Reading time &asymp;</span>
      <span>3 mins.</span>
    </span>
</div>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">
        <dl>
<dt>抗原（antigen, <abbr title="抗原">Ag</abbr>）</dt>
<dd>所有能激活和诱导免疫应答的物质。</dd>
<dd>通常指能被 T、B 淋巴细胞表面特异性抗原受体识别及结合，激活 T、B 细胞增殖、分化、产生免疫应答效应产物（<strong>免疫原性</strong>），并与效应产物结合（<strong>免疫反应性</strong>），进而发挥适应性免疫应答效应的物质。</dd>
</dl>
<span id="more"></span>
<h2 id="抗原的性质与分子结构基础">抗原的性质与分子结构基础 <a class="markdownIt-Anchor" href="#抗原的性质与分子结构基础">#</a></h2>
<h3 id="抗原的基本特征">抗原的基本特征 <a class="markdownIt-Anchor" href="#抗原的基本特征">#</a></h3>
<dl>
<dt>免疫原性（immunogenicity）</dt>
<dd>抗原被 <abbr title="T 细胞表面抗原">TCR</abbr> 或 <abbr title="B 细胞表面抗原">BCR</abbr> 识别及结合，诱导机体产生适应性免疫及产生抗体或特异性淋巴细胞的能力。</dd>
</dl>
<dl>
<dt>免疫反应性（immunoreactivity）| 抗原性</dt>
<dd>抗原与其诱导产生的免疫应答效应物质特异性结合的能力。</dd>
</dl>
<h3 id="适应性免疫应答的抗原特异性">适应性免疫应答的抗原特异性 <a class="markdownIt-Anchor" href="#适应性免疫应答的抗原特异性">#</a></h3>
<h4 id="抗原特异性与抗原表位">抗原特异性与抗原表位 <a class="markdownIt-Anchor" href="#抗原特异性与抗原表位">#</a></h4>
<dl>
<dt>抗原特异性（antigenic specificity）</dt>
<dd>抗原刺激机体产生适应性免疫应答及其与应答效应产物发生结合均表现出专一性。</dd>
<dt>抗原表位（epitope） | 抗原决定簇（/基）（antigenic determinant）</dt>
<dd>抗原分子中决定抗原特异性的特殊化学基团。</dd>
<dd>是抗原与 <abbr title="T 细胞表面抗原">TCR</abbr>/<abbr title="B 细胞表面抗原">BCR</abbr> 或者抗体特异性结合的<strong>最小结构和功能单位</strong>。</dd>
</dl>
<div class="note default"><p>抗体和抗原上的某一个<strong>表位</strong>结合具有特异性，而一个抗原上可存在多个表位。</p>
</div>
<dl>
<dt>抗原结合价（antigenic valence）</dt>
<dd>一个抗原分子中能够与抗体分子结合的抗原表位的总数。</dd>
</dl>
<blockquote>
<p>天然抗原是多价抗原。</p>
</blockquote>
<h4 id="抗原表位的分类">抗原表位的分类 <a class="markdownIt-Anchor" href="#抗原表位的分类">#</a></h4>
<p>根据抗原表位中氨基酸的空间结构特点，可分为：</p>
<dl>
<dt>顺序表位（sequential epitope）| 线性表位（linear epitope）</dt>
<dd>由线性排列的氨基酸构成。</dd>
<dt>构象表位（conformational epitope）</dt>
<dd>由不连续排列、但在空间上彼此接近形成特定构象的氨基酸构成。</dd>
</dl>
<hr />
<p>根据 T、B 细胞所识别的表位不同，可分为：</p>
<dl>
<dt>T 细胞表位</dt>
<dd><ins>可位于抗原分子的任何部位</ins>，由 <abbr title="抗原提呈细胞">APC</abbr> 降解为<strong>线性表位</strong>、结合于 <abbr title="主要组织相容性复合体（major histocompatibility complex）">MHC</abbr> 分子沟槽并提呈于 <abbr title="抗原提呈细胞">APC</abbr> 表面，供 <abbr title="T 细胞表面抗原">TCR</abbr> 识别。
<ul>
<li>CD8<sup>+</sup>T 细胞识别的表位：8~10 个氨基酸，第 2、9 位为<strong>锚定氨基酸</strong>（anchor residue）</li>
<li>CD4<sup>+</sup>T 细胞识别的表位：13~17 个氨基酸</li>
</ul>
</dd>
</dl>
<dl>
<dt>B 细胞表位</dt>
<dd>无需 <abbr title="抗原提呈细胞">APC</abbr> 加工和提呈，<ins>位于抗原分子表面</ins>，多为<strong>构象表位</strong>，少数为<strong>线性表位</strong>，供 <abbr title="B 细胞表面抗原">BCR</abbr> 识别。</dd>
</dl>
<h4 id="半抗原-载体反应">半抗原-载体反应 <a class="markdownIt-Anchor" href="#半抗原-载体反应">#</a></h4>
<dl>
<dt>完全抗原（complete antigen）| 免疫原（immunogen）</dt>
<dd>同时具有<strong>免疫原性</strong>和<strong>免疫反应性</strong>的物质，即通常所说的抗原。</dd>
<dt>半抗原（hapten）| 不完全抗原（incomplete antigen）</dt>
<dd>可与抗体结合（<strong>免疫原性</strong>）而不能单独诱导免疫应答（<strong><s>免疫反应性</s></strong>，<ins>可特异性结合 <abbr title="B 细胞表面抗原">BCR</abbr>，但不足以活化 B 细胞</ins>），但与
<strong>蛋白载体</strong>交联或结合和可获得<strong>免疫反应性</strong>。</dd>
<dt><em>蛋白载体</em></dt>
<dd>可赋予半抗原免疫原性的大分子蛋白质。</dd>
<dd>含 CD4<sup>+</sup>T 细胞表位，可活化 CD4<sup>+</sup>T 细胞。</dd>
</dl>
<p>对<strong>人工抗原</strong>（半抗体+载体），B 细胞识别半抗原的 B 细胞表位；CD4<sup>+</sup>T 细胞识别载体蛋白的
T 细胞表位。</p>
<blockquote>
<p>一个半抗原相当于一个抗原表位。</p>
</blockquote>
<p>天然蛋白抗原同时存在 T、B 细胞表位，可分别激活 T 细胞和 B 细胞，其中 B 细胞激活有赖于
T 细胞辅助。</p>
<p>半抗原须与蛋白质载体偶联才可诱导抗体产生：</p>
<ol>
<li><strong>半抗原</strong>特异性结合 <abbr title="B 细胞表面抗原">BCR</abbr>，但是不足以活化 B 细胞</li>
<li><strong>蛋白载体</strong>含 CD4<sup>+</sup>T 细胞表位，可活化 CD4<sup>+</sup>T 细胞</li>
</ol>
<h4 id="共同抗原表位与交叉反应">共同抗原表位与交叉反应 <a class="markdownIt-Anchor" href="#共同抗原表位与交叉反应">#</a></h4>
<dl>
<dt>共同抗原表位（common epitope）</dt>
<dd>不同抗原间含有的相同或相似抗原表位。</dd>
<dt>交叉抗原（cross antigen）</dt>
<dd>含有共同抗原表位的不同抗原。</dd>
</dl>
<h2 id="影响抗原免疫原性的因素">影响抗原免疫原性的因素 <a class="markdownIt-Anchor" href="#影响抗原免疫原性的因素">#</a></h2>
<h3 id="抗原分子的理化与结构性质">抗原分子的理化与结构性质 <a class="markdownIt-Anchor" href="#抗原分子的理化与结构性质">#</a></h3>
<ol>
<li><strong>异物性</strong>：抗原与机体<ins>亲缘越远</ins>，组织结构差异越大，免疫原性越强</li>
<li><strong>化学属性</strong>：<ins>大分子</ins>有机物和<ins>蛋白质</ins>免疫原性较强</li>
<li><strong>分子量</strong>：<ins>分子量越大</ins>，一般含抗原表位越多，免疫原性越强</li>
<li><strong>分子结构</strong>：分子量越大，<ins>结构越复杂</ins>，免疫原性越强</li>
<li><strong>分子构象</strong>：抗原大分子中所含<ins>抗原表位的性质、数目、位置和空间构象</ins>均可影响抗原的免疫原性和免疫反应性</li>
<li><strong>易接近性</strong>：抗原表位在空间上<ins>被 <abbr title="B 细胞表面抗原">BCR</abbr> 接近</ins>的程度，显著影响免疫原性</li>
<li><strong>物理性质</strong>：
<ul>
<li><ins>聚合态</ins>、<ins>颗粒性</ins>抗原与单体和可溶性抗原相比，免疫原性更强</li>
<li>将免疫原性弱的物质<ins>吸附于颗粒物质表面或组装为颗粒性物质</ins>，可显著增强其免疫原性</li>
</ul>
</li>
</ol>
<h3 id="宿主的特性">宿主的特性 <a class="markdownIt-Anchor" href="#宿主的特性">#</a></h3>
<ol>
<li><strong>遗传因素</strong>：<abbr title="主要组织相容性复合体（major histocompatibility complex）">MHC</abbr> 基因呈高度多态性，从遗传上决定个体对抗原的应答与否及应答程度</li>
<li><strong>年龄、性别、健康状态</strong>：
<ul>
<li>幼、老年免疫应答弱</li>
<li>雌性诱导产生抗体能力强，自身免疫率增高</li>
</ul>
</li>
</ol>
<h3 id="抗原进入宿主的方式">抗原进入宿主的方式 <a class="markdownIt-Anchor" href="#抗原进入宿主的方式">#</a></h3>
<ol>
<li><strong>抗原剂量</strong>：过低、过高都以诱导免疫耐受</li>
<li><strong>抗原进入机体的途径影响免疫应答强度</strong>：<mark>皮内、皮下&gt;肌肉&gt;静脉&gt;口服</mark></li>
<li>抗原进入机体的时间间隔：适当间隔（如 1~2 周）可诱导较好的免疫应答，频繁注射易引起免疫耐受</li>
<li>佐剂：见 <a href="#%E9%9D%9E%E7%89%B9%E5%BC%82%E6%80%A7%E5%85%8D%E7%96%AB%E5%88%BA%E6%BF%80%E5%89%82">非特异性免疫刺激剂</a></li>
</ol>
<h2 id="抗原的种类">抗原的种类 <a class="markdownIt-Anchor" href="#抗原的种类">#</a></h2>
<h3 id="根据诱生抗体时是否需要-th-细胞参与">根据诱生抗体时是否需要 Th 细胞参与 <a class="markdownIt-Anchor" href="#根据诱生抗体时是否需要-th-细胞参与">#</a></h3>
<dl>
<dt>胸腺依赖性抗原（thymus dependent antigen, TD-<abbr title="抗原">Ag</abbr>）</dt>
<dd>绝大多数蛋白质抗原刺激 B 细胞产生抗体时，需要 T 细胞的辅助。</dd>
<dt>非胸腺依赖性抗原（thymus independent antigen, TI-<abbr title="抗原">Ag</abbr>）</dt>
<dd>可非特异性激活多克隆 B 细胞，产生抗体时无需 T 细胞的辅助。
<ul>
<li>TI-1Ag
<ul>
<li>既含有重复 B 细胞表位，又具有 B 细胞丝裂原性质</li>
<li>可特异性或非特异性激活 B 细胞</li>
</ul>
</li>
<li>TI-2Ag
<ul>
<li>既含有重复 B 细胞表位</li>
<li>通过交联 <abbr title="B 细胞表面抗原">BCR</abbr> 刺激成熟 B 细胞应答</li>
</ul>
</li>
</ul>
</dd>
</dl>
<p class="align-text-center table-caption ">
      TD-Ag 与 TI-Ag 对比
    </p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align:center">TD-<abbr title="抗原">Ag</abbr></th>
<th style="text-align:center">TI-<abbr title="抗原">Ag</abbr></th>
</tr>
</thead>
<tbody>
<tr>
<td>结构特点</td>
<td style="text-align:center">复杂，含多种表位</td>
<td style="text-align:center">含单一表位</td>
</tr>
<tr>
<td>表位组成</td>
<td style="text-align:center">B 细胞和 T 细胞表位</td>
<td style="text-align:center">重复 B 细胞表位</td>
</tr>
<tr>
<td>T 细胞辅助</td>
<td style="text-align:center">必需</td>
<td style="text-align:center">无需</td>
</tr>
<tr>
<td><abbr title="主要组织相容性复合体（major histocompatibility complex）">MHC</abbr> 限制性</td>
<td style="text-align:center">有</td>
<td style="text-align:center">无</td>
</tr>
<tr>
<td>激活的 B 细胞</td>
<td style="text-align:center">B2</td>
<td style="text-align:center">B1</td>
</tr>
<tr>
<td>免疫应答类型</td>
<td style="text-align:center">体液免疫和细胞免疫</td>
<td style="text-align:center">细胞免疫</td>
</tr>
<tr>
<td>抗体类型</td>
<td style="text-align:center">IgM、IgG、IgA 等</td>
<td style="text-align:center">IgM</td>
</tr>
<tr>
<td>免疫记忆</td>
<td style="text-align:center">有</td>
<td style="text-align:center">无</td>
</tr>
</tbody>
</table>
<h3 id="根据抗原与机体的亲缘关系">根据抗原与机体的亲缘关系 <a class="markdownIt-Anchor" href="#根据抗原与机体的亲缘关系">#</a></h3>
<p>另见 <a href="/Learning/Medicine/%E5%8C%BB%E5%AD%A6%E5%85%8D%E7%96%AB%E5%AD%A6/%E6%8A%97%E4%BD%93/#抗体的多样性和免疫原性">抗体的多样性和免疫原性</a>。</p>
<dl>
<dt>异嗜性抗原 | Forssman 抗原</dt>
<dd>存在于人、动物及微生物等不同种属间的共同抗原。</dd>
<dd>与人体自身物质存在<strong>共同表位</strong>的病菌侵入人体可导致自身免疫。</dd>
<dt>异种抗原</dt>
<dd>另一物种来源的抗原。</dd>
<dt>同种异型抗原 | 同种异体抗原</dt>
<dd>同一物种不同个体间存在的不同抗原，如血型抗原和人 <abbr title="主要组织相容性复合体（major histocompatibility complex）">MHC</abbr>（即 <abbr title="人白细胞抗原">HLA</abbr>）。</dd>
</dl>
<div class="note info"><p>HLA（人白细胞抗原）是人群中多态性最高的同种异型抗原，成为个体区别于他人的
<strong>独特遗传标志</strong>，是介导人体间<strong>移植排斥反应</strong>的主要移植抗原。</p>
</div>
<dl>
<dt>自身抗原</dt>
<dd>发生改变或修饰的自身组织细胞成分、外伤导致释放的<strong>免疫隔离</strong>的自身物质。</dd>
<dd>产生原因：
<ul>
<li>隐蔽抗原释放：晶状体蛋白（交感性眼炎）、精子（自身免疫性睾丸炎）</li>
<li>自身抗原被修饰：生物因素、化学修饰、物理修饰</li>
</ul>
</dd>
<dt><a href="/Learning/Medicine/%E5%8C%BB%E5%AD%A6%E5%85%8D%E7%96%AB%E5%AD%A6/%E6%8A%97%E4%BD%93/#抗体的多样性和免疫原性">独特型</a>（idiotype, Id）抗原（idiotypic antigen）</dt>
<dd>具有<strong>免疫原性</strong>，可刺激机体内的其他 B 细胞产生相应抗体的<strong>抗体</strong>，其上抗原表位称为<strong>独特型抗原</strong>。</dd>
<dd>Id 抗原诱导产生的抗体（即<strong>抗抗体</strong>），称为<strong>抗独特型抗体</strong>（AId）。</dd>
</dl>
<h3 id="根据抗原提呈细胞内抗原的来源">根据抗原提呈细胞内抗原的来源 <a class="markdownIt-Anchor" href="#根据抗原提呈细胞内抗原的来源">#</a></h3>
<dl>
<dt>内源性抗原（endogenous antibody）</dt>
<dd>在 <abbr title="抗原提呈细胞">APC</abbr> 内新合成的抗原，如病毒感染细胞合成的病毒蛋白、肿瘤细胞合成的肿瘤抗原等。</dd>
<dd>在胞质内被处理为抗原肽与 <strong><abbr title="主要组织相容性复合体（major histocompatibility complex）">MHC</abbr> Ⅰ 类分子</strong>结合，激活 <strong>CD8<sup>+</sup>T 细胞</strong>。</dd>
<dt>外源性抗原（exogenous antibody）</dt>
<dd>细菌蛋白等外来抗原。</dd>
<dd>通过胞吞、胞饮或受体介导内吞进入 <abbr title="抗原提呈细胞">APC</abbr>，在内体-溶酶体中被降解为抗原肽并与
<strong><abbr title="主要组织相容性复合体（major histocompatibility complex）">MHC</abbr> Ⅱ 类分子</strong>结合，提呈于 <abbr title="抗原提呈细胞">APC</abbr> 表面，激活 <strong>CD4<sup>+</sup>T 细胞</strong>。</dd>
</dl>
<h2 id="非特异性免疫刺激剂">非特异性免疫刺激剂 <a class="markdownIt-Anchor" href="#非特异性免疫刺激剂">#</a></h2>
<h3 id="超抗原">超抗原 <a class="markdownIt-Anchor" href="#超抗原">#</a></h3>
<dl>
<dt>超抗原（superantigen，SAg）</dt>
<dd>某些只需极低浓度（1~10ng/ml）即可非特异性激活人体总 T 细胞库中 2%~20% 的 T
细胞克隆，产生极强的免疫应答的抗原物质，其实质为<strong>多克隆抑制剂</strong>。</dd>
</dl>
<p class="align-text-center table-caption ">
      超抗原和普通抗原的区别
    </p>
<table>
<thead>
<tr>
<th></th>
<th>超抗原</th>
<th>普通抗原</th>
</tr>
</thead>
<tbody>
<tr>
<td>化学性质</td>
<td>菌体外毒素、逆转录病毒蛋白等</td>
<td>普通蛋白质、多糖等</td>
</tr>
<tr>
<td><abbr title="主要组织相容性复合体（major histocompatibility complex）">MHC</abbr> 结合部位</td>
<td><strong>抗原结合槽外部</strong></td>
<td>抗原结合槽内部</td>
</tr>
<tr>
<td><abbr title="T 细胞表面抗原">TCR</abbr> 结合部位</td>
<td><strong>Vβ 链</strong> CDR3 外侧区域</td>
<td>Vα、Jα 及 Vβ、Dβ、Jβ</td>
</tr>
<tr>
<td>应答特点</td>
<td>直接激活大量 T 细胞</td>
<td><abbr title="抗原提呈细胞">APC</abbr> 加工后激活特异性 T 细胞</td>
</tr>
<tr>
<td>反应细胞</td>
<td>CD4<sup>+</sup> 细胞</td>
<td>T、B 细胞</td>
</tr>
<tr>
<td>T 细胞库反应频率</td>
<td>1/50~1/5（2%~20%）</td>
<td>1/10<sup>6</sup>~1/10<sup>4</sup></td>
</tr>
</tbody>
</table>
<h3 id="佐剂">佐剂 <a class="markdownIt-Anchor" href="#佐剂">#</a></h3>
<dl>
<dt>佐剂（adjuvant）</dt>
<dd>预先或与抗原同时注入体内，增强抗原特异性免疫应答或改变应答类型的非特异性免疫增强物质。</dd>
</dl>
<h4 id="佐剂的类型">佐剂的类型 <a class="markdownIt-Anchor" href="#佐剂的类型">#</a></h4>
<ol>
<li><strong>生物性佐剂</strong>：卡介苗</li>
<li><strong>无机化合物</strong>：氢氧化铝</li>
<li><strong>人工合成物</strong>：低甲基化 CpG 寡核苷酸</li>
<li><strong>有机物</strong>：矿物油</li>
<li><strong>脂质体</strong>：免疫刺激复合物</li>
</ol>
<p>动物实验常用<strong>弗氏完全佐剂</strong>（Freund complete adjuvant，FCA） 和<strong>弗氏不完全佐剂</strong>（Freund incomplete adjuvant，FIA）。</p>
<p class="align-text-center table-caption ">
      两种弗氏佐剂对比
    </p>
<table>
<thead>
<tr>
<th></th>
<th>弗氏不完全佐剂</th>
<th>弗氏完全佐剂</th>
</tr>
</thead>
<tbody>
<tr>
<td>成分</td>
<td>矿物油</td>
<td>矿物油、灭活结核分枝杆菌</td>
</tr>
<tr>
<td>增强的免疫应答类型</td>
<td>体液免疫</td>
<td>体液免疫、细胞免疫</td>
</tr>
</tbody>
</table>
<h4 id="佐剂作用机制">佐剂作用机制 <a class="markdownIt-Anchor" href="#佐剂作用机制">#</a></h4>
<ol>
<li><strong>改变抗原物理性质</strong>，延缓抗原降解；</li>
<li><strong>刺激抗原提呈细胞</strong>，增强其对抗原的加工和提呈；</li>
<li><strong>刺激淋巴细胞增殖分化</strong>，增强和扩大免疫应答。</li>
</ol>
<h3 id="丝裂原">丝裂原 <a class="markdownIt-Anchor" href="#丝裂原">#</a></h3>
<dl>
<dt>丝裂原（mitogen）| 有丝分裂原</dt>
<dd>属于非特异性淋巴细胞多克隆激活剂，通过与淋巴细胞表面<strong>丝裂原受体</strong>
结合，刺激静止淋巴细胞转化为淋巴母细胞并进行有丝分裂，从而激活一类淋巴细胞的全部克隆。</dd>
</dl>

    </div>

    
    
    

    <footer class="post-footer">
          

<div class="post-copyright">
<ul>
  <li class="post-copyright-author">
      <strong>Post author:  </strong>Qihuan Liu
  </li>
  <li class="post-copyright-link">
      <strong>Post link: </strong>
      <a href="https://www.aloha.org.cn/Learning/Medicine/%E5%8C%BB%E5%AD%A6%E5%85%8D%E7%96%AB%E5%AD%A6/%E6%8A%97%E5%8E%9F/" title="抗原">https://www.aloha.org.cn/Learning/Medicine/医学免疫学/抗原/</a>
  </li>
  <li class="post-copyright-license">
    <strong>Copyright Notice:  </strong>All articles in this blog are licensed under <span class="exturl" data-url="aHR0cHM6Ly9jcmVhdGl2ZWNvbW1vbnMub3JnL2xpY2Vuc2VzL2J5LW5jLXNhLzQuMC9kZWVkLnpo"><i class="fab fa-fw fa-creative-commons"></i>BY-NC-SA</span> unless stating additionally.
  </li>
</ul>
</div>

          <div class="post-tags">
              <a href="/tags/%E5%8C%BB%E5%AD%A6%E5%85%8D%E7%96%AB%E5%AD%A6/" rel="tag"><i class="fa fa-tag"></i> 医学免疫学</a>
          </div>

        

          <div class="post-nav">
            <div class="post-nav-item">
                <a href="/Learning/Computer/Front-end/Vue-%E5%AD%A6%E4%B9%A0%E8%AE%B0%E5%BD%95/" rel="prev" title="Vue 学习记录">
                  <i class="fa fa-chevron-left"></i> Vue 学习记录
                </a>
            </div>
            <div class="post-nav-item">
                <a href="/Learning/Computer/C-C/CMake-%E5%AD%A6%E4%B9%A0%E8%AE%B0%E5%BD%95/" rel="next" title="CMake 学习记录">
                  CMake 学习记录 <i class="fa fa-chevron-right"></i>
                </a>
            </div>
          </div>
    </footer>
  </article>
</div>






    <div class="comments utterances-container"></div><script src="/js/comments.js"></script>
</div>
  </main>

  <footer class="footer">
    <div class="footer-inner">


<div class="copyright">
  &copy; 
  <span itemprop="copyrightYear">2021</span>
  <span class="with-love">
    <i class="fa fa-heart"></i>
  </span>
  <span class="author" itemprop="copyrightHolder">Qihuan Liu</span>
</div>
<div class="wordcount">
  <span class="post-meta-item">
    <span class="post-meta-item-icon">
      <i class="fa fa-chart-line"></i>
    </span>
      <span>Symbols count total: </span>
    <span title="Symbols count total">199k</span>
  </span>
  <span class="post-meta-item">
    <span class="post-meta-item-icon">
      <i class="fa fa-coffee"></i>
    </span>
      <span>Reading time total &asymp;</span>
    <span title="Reading time total">3:01</span>
  </span>
</div>
  <div class="powered-by">Powered by <span class="exturl" data-url="aHR0cHM6Ly9oZXhvLmlv">Hexo</span> & <span class="exturl" data-url="aHR0cHM6Ly90aGVtZS1uZXh0LmpzLm9yZy9taXN0Lw==">NexT.Mist</span>
  </div>

    </div>
  </footer>

  
  <script src="https://cdn.jsdelivr.net/npm/animejs@3.2.1/lib/anime.min.js" integrity="sha256-XL2inqUJaslATFnHdJOi9GfQ60on8Wx1C2H8DYiN1xY=" crossorigin="anonymous"></script>
  <script src="https://cdn.jsdelivr.net/npm/@next-theme/pjax@0.5.0/pjax.min.js" integrity="sha256-3NkoLDrmHLTYj7csHIZSr0MHAFTXth7Ua/DDt4MRUAg=" crossorigin="anonymous"></script>
  <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.0/dist/jquery.min.js" integrity="sha256-/xUj+3OJU5yExlq6GSYGSHk7tPXikynS7ogEvDej/m4=" crossorigin="anonymous"></script>
  <script src="https://cdn.jsdelivr.net/npm/@fancyapps/fancybox@3.5.7/dist/jquery.fancybox.min.js" integrity="sha256-yt2kYMy0w8AbtF89WXb2P1rfjcP/HTHLT7097U8Y5b8=" crossorigin="anonymous"></script>
  <script src="https://cdn.jsdelivr.net/npm/lozad@1.16.0/dist/lozad.min.js" integrity="sha256-mOFREFhqmHeQbXpK2lp4nA3qooVgACfh88fpJftLBbc=" crossorigin="anonymous"></script>
<script src="/js/utils.js"></script><script src="/js/motion.js"></script><script src="/js/schemes/muse.js"></script><script src="/js/next-boot.js"></script><script src="/js/bookmark.js"></script><script src="/js/pjax.js"></script>

  
<script src="/js/third-party/search/local-search.js"></script>



  <script class="next-config" data-name="pdf" type="application/json">{&quot;object_url&quot;:{&quot;url&quot;:&quot;https:&#x2F;&#x2F;cdn.jsdelivr.net&#x2F;npm&#x2F;pdfobject@2.2.5&#x2F;pdfobject.min.js&quot;,&quot;integrity&quot;:&quot;sha256-YuNlP9i6s&#x2F;WH7EaU2kErloo9Vc85C3WVqhoMDgsEVpY&#x3D;&quot;},&quot;url&quot;:&quot;&#x2F;lib&#x2F;pdf&#x2F;web&#x2F;viewer&quot;}</script>
  <script src="/js/third-party/tags/pdf.js"></script>

  <script class="next-config" data-name="mermaid" type="application/json">{&quot;enable&quot;:true,&quot;theme&quot;:&quot;forest&quot;,&quot;js&quot;:{&quot;url&quot;:&quot;https:&#x2F;&#x2F;cdn.jsdelivr.net&#x2F;npm&#x2F;mermaid@8.9.3&#x2F;dist&#x2F;mermaid.min.js&quot;,&quot;integrity&quot;:&quot;sha256-OyJHvRcZHaRR6Ig73ppxF4QXk8HzvfgTprRWkulCkfY&#x3D;&quot;}}</script>
  <script src="/js/third-party/tags/mermaid.js"></script>

  <script class="next-config" data-name="nprogress" type="application/json">{&quot;enable&quot;:true,&quot;spinner&quot;:true}</script>
  <script src="/js/third-party/nprogress.js"></script>

  




  

  <script class="next-config" data-name="enableMath" type="application/json">false</script><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.13.3/dist/katex.min.css" integrity="sha256-ZtdsMkDnoWbkrm82KV9pXHJCBx4mzAuAkBEMswmVH5M=" crossorigin="anonymous">
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.13.3/dist/contrib/copy-tex.min.css" integrity="sha256-+oItviPaTmqjDhk4y4fLLUIMgRQYDV/ZyrRNvQiebWM=" crossorigin="anonymous">
  <script class="next-config" data-name="katex" type="application/json">{&quot;copy_tex_js&quot;:{&quot;url&quot;:&quot;https:&#x2F;&#x2F;cdn.jsdelivr.net&#x2F;npm&#x2F;katex@0.13.3&#x2F;dist&#x2F;contrib&#x2F;copy-tex.min.js&quot;,&quot;integrity&quot;:&quot;sha256-etSqbSVF4+Lwe8MGk&#x2F;Vanc1sR+mWv+qOG73fxWw9p94&#x3D;&quot;}}</script>
  <script src="/js/third-party/math/katex.js"></script>


<script class="next-config" data-name="utterances" type="application/json">{&quot;enable&quot;:true,&quot;repo&quot;:&quot;alohaia&#x2F;alohaia.github.io&quot;,&quot;issue_term&quot;:&quot;title&quot;,&quot;theme&quot;:&quot;preferred-color-scheme&quot;}</script>
<script src="/js/third-party/comments/utterances.js"></script>

</body>
</html>
